PHVS (pharvaris.com) Bozor qiymatining balans qiymatiga nisbati
Pharvaris N.V. (PHVS) uchun asosiy drayver irsiy angioedema uchun innovatsion planshetga asoslangan davolash vositasini ishlab chiqishdir, buni narxlar grafigi tasdiqlaydi, u yerda ko'rsatkich 6.55 qiymatida qotgan. Ushbu biotexnologiya firmasi kam uchraydigan kasalliklar terapiyalariga e'tibor qaratgan holda, energiyani tejovchi texnologiyalarni va yopiq suv siklini joriy qilmoqda. Biznes muvaffaqiyati tartibga soluvchi organlarning tasdiqlari hamda barqaror investitsiya kapitali tomonidan qo'llab-quvvatlanadigan ehtiyotkor xarajatlar boshqaruviga bog'liq.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_PHVS_-_Pharvaris-N.V._-_Market-Capitalization-to-Net-Assets "PHVS Pharvaris Pharma Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Pharvaris NV (PHVS) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Pharvaris N.V.|PHVS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pharvaris Corp|PHVS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pharvaris Corp|PHVS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Pharvaris
Kompaniyaning dastlabki tahlili:Pharvaris N.V. - PHVS
Ushbu koeffitsiyent barcha aksiyalarning umumiy bozor qiymatining sof aktivlar yig'indisiga nisbati sifatida hisoblanadi va bozor narxining real kapitalga nisbatan premiumi yoki diskontini aks ettiradi. Outsorsing ishlab chiqarishdan foydalanadigan Pharvaris N.V. (PHVS) uchun GURU.Markets dagi kitob qiymatiga nisbatan joriy bozor kapitalizatsiyasi baholashi kompaniyaning jismoniy aktivlar qiymatida aks etmagan intellektual kapital va kelgusidagi ishlanmalarning qiymatini namoyish etadi.
Asosiy raqobatchilar
argenx SE - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|AbCellera Bio (ABCL) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Tourmaline Bio Inc (TRML)|Bozor kapitallashuvining balans qiymatiga nisbati PGEN|Pharming Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|NKTR: Bozor qiymatining balans qiymatiga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Biopharma) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Rigel Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati AnaptysBio Corp|ATXS - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati enGene Holdings Inc. ENGN|rapt.com (RAPT) - Balans qiymatiga nisbatan bozor qiymati|JBIO (Aerovate Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|Kyverna (KYTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Tiziana Life Sciences, Ltd. TLSA|Kapitallashuvning sof aktivlarga nisbati Cabaletta Bio, Inc. CABA|Bozor qiymatining balans qiymatiga nisbati ventyxbio.com VTYX|Theratechnologies - Bozor kapitallashuvining balans qiymatiga nisbati|AVTX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Eledon ELDN|Agenus, Inc (AGEN) - Balans qiymatiga nisbatan bozor qiymati|CLYM: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ZURA|ATYR (aTyr Pharma) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi adagene.com ADAG|Kapitallashuvning sof aktivlarga nisbati Ikena Oncology|Shattuck Labs Inc - Balans qiymatiga nisbatan bozor qiymati|Equillium Bio (EQ) - Bozor qiymatining balans qiymatiga nisbati|Connect Biopharma (CNTB) - Kapitallashuvning balans qiymatiga nisbati|immunic-therapeutics.com - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Atara Bio|Kapitallashuvning sof aktivlarga nisbati InflaRx NV|Bozor qiymatining balans qiymatiga nisbati X4 Pharmaceuticals, Inc (XFOR)|ACET (Adicet Bio) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CELU (celularity.com)|INmune Bio (INMB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|Bozor kapitallashuvining balans qiymatiga nisbati Kezar Life Sciences, Inc (KZR)|SAB Biotherapeutics Inc (SABS) - Balans qiymatiga nisbatan bozor qiymati|Akari Therapeutics (AKTX) - Kapitallashuvning sof aktivlarga nisbati|ENLV (Enlivex Therapeutics Ltd.) - Bozor qiymatining balans qiymatiga nisbati|QTTB: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GOVX|EDSA - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati Carisma Therapeutics Inc.|Balans qiymatiga nisbatan bozor qiymati xtlbio.com XTLB|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aptevotherapeutics.com APVO|AIM (aimimmuno.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati ADTX|Kapitallashuvning sof aktivlarga nisbati gribio.com|Bozor kapitallashuvining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati Vyome Holdings Inc. HIND|Kapitallashuvning sof aktivlarga nisbati Revelation Bio|Balans qiymatiga nisbatan bozor qiymati Indaptus Corp INDP|Bozor kapitallashuvining balans qiymatiga nisbati SCNI (Scinai Immunotherapeutics)|CALI: Balans qiymatiga nisbatan bozor kapitallashuvi|AFMD (affimed.com) - Bozor qiymatining balans qiymatiga nisbati|ALLK (Allakos) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOK|Kapitallashuvning sof aktivlarga nisbati IGM Bio (IGMS)|Kapitallashuvning sof aktivlarga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati OCEA (oceanbiomedical.com)|TCBP - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Third Harmonic Bio Inc. THRD